NASDAQ:EDAPEdap Tms Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Edap Tms SA Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.28 +0.08 (+2.50 %) (As of 08/7/2020 04:00 PM ET) Add Compare Share Today's Range$3.14Now: $3.28▼$3.3050-Day Range$2.36MA: $2.83▼$3.4252-Week Range$1.46Now: $3.28▼$5.39Volume2,314 shsAverage Volume159,390 shsMarket Capitalization$95.12 millionP/E Ratio46.86Dividend YieldN/ABeta1.68 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells consumables; and offers treatment related services and maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is headquartered in Vaulx-en-Velin, France.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingEdap Tms has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.25, Edap Tms has a potential upside of 60.1% from its current price of $3.28.Amount of Analyst CoverageEdap Tms has received no research coverage in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesEdap Tms has received 327 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEdap Tms has received 325 “underperform” votes. (Add your “underperform” vote.)Community SentimentEdap Tms has received 50.15% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote “Outperform” if you believe EDAP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEdap Tms does not currently pay a dividend.Dividend GrowthEdap Tms does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Edap Tms insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 18.16% of the stock of Edap Tms is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Edap Tms is 46.86, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Edap Tms is 46.86, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 32.86.Price to Book Value per Share RatioEdap Tms has a P/B Ratio of 3.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.20 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EDAP Previous Symbol CUSIPN/A CIK1041934 Webwww.edap-tms.com Phone33-04-72-15-31-50Debt Debt-to-Equity Ratio0.06 Current Ratio2.41 Quick Ratio1.94Price-To-Earnings Trailing P/E Ratio46.86 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$50.23 million Price / Sales1.89 Cash Flow$0.14 per share Price / Cash Flow24.07 Book Value$1.06 per share Price / Book3.09Profitability EPS (Most Recent Fiscal Year)$0.06 Net Income$1.69 million Net Margins4.38% Return on Equity20.15% Return on Assets10.39%Miscellaneous Employees215 Outstanding Shares29,000,000Market Cap$95.12 million Next Earnings Date8/26/2020 (Estimated) OptionableOptionable $3.28 +0.08 (+2.50 %) (As of 08/7/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive EDAP News and Ratings via Email Sign-up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter. Edap Tms (NASDAQ:EDAP) Frequently Asked Questions How has Edap Tms' stock been impacted by COVID-19 (Coronavirus)? Edap Tms' stock was trading at $2.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EDAP stock has increased by 32.3% and is now trading at $3.28. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Edap Tms? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Edap Tms. When is Edap Tms' next earnings date? Edap Tms is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Edap Tms. How were Edap Tms' earnings last quarter? Edap Tms SA (NASDAQ:EDAP) announced its quarterly earnings results on Wednesday, May, 13th. The medical equipment provider reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.02. The medical equipment provider had revenue of $8.30 million for the quarter, compared to analyst estimates of $9.02 million. Edap Tms had a net margin of 4.38% and a return on equity of 20.15%. View Edap Tms' earnings history. What price target have analysts set for EDAP? 2 analysts have issued 1-year price targets for Edap Tms' shares. Their forecasts range from $5.00 to $5.50. On average, they expect Edap Tms' share price to reach $5.25 in the next year. This suggests a possible upside of 60.1% from the stock's current price. View analysts' price targets for Edap Tms. Has Edap Tms been receiving favorable news coverage? Media coverage about EDAP stock has been trending very positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Edap Tms earned a news impact score of 4.0 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Edap Tms. Who are some of Edap Tms' key competitors? Some companies that are related to Edap Tms include Semler Scientific (SMLR), Stereotaxis (STXS), Cutera (CUTR), BioSig Technologies (BSGM), Fonar (FONR), electroCore (ECOR), Soleno Therapeutics (SLNO), Fc Global Realty (FCRE), IRIDEX (IRIX), CHF Solutions (CHFS), Helius Medical Technologies (HSDT), Second Sight Medical Products (EYES), Reshape Lifesciences (RSLS), ENDRA Life Sciences (NDRA) and Precision Optics (PEYE). View all competitors. What other stocks do shareholders of Edap Tms own? Based on aggregate information from My MarketBeat watchlists, some companies that other Edap Tms investors own include Energous (WATT), Weatherford International (WFT), CTI BioPharma (CTIC), PETROLEO BRASIL/ADR (PBR), Kandi Technologies Group (KNDI), Misonix (MSON), Achillion Pharmaceuticals (ACHN), Advanced Micro Devices (AMD), Destination Maternity (DESTQ) and Pacific Drilling (PACDQ). Who are Edap Tms' key executives? Edap Tms' management team includes the following people: Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)Mr. Franois Dietsch, Chief Financial Officer (Age 43)Ms. Blandine Confort, Investor Relations Officer and Sec. What is Edap Tms' stock symbol? Edap Tms trades on the NASDAQ under the ticker symbol "EDAP." Who are Edap Tms' major shareholders? Edap Tms' stock is owned by a number of institutional and retail investors. Top institutional investors include Accredited Investors Inc. (0.46%) and Envestnet Asset Management Inc. (0.05%). Which institutional investors are selling Edap Tms stock? EDAP stock was sold by a variety of institutional investors in the last quarter, including Accredited Investors Inc.. Which institutional investors are buying Edap Tms stock? EDAP stock was acquired by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc.. How do I buy shares of Edap Tms? Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Edap Tms' stock price today? One share of EDAP stock can currently be purchased for approximately $3.28. How big of a company is Edap Tms? Edap Tms has a market capitalization of $95.12 million and generates $50.23 million in revenue each year. The medical equipment provider earns $1.69 million in net income (profit) each year or $0.06 on an earnings per share basis. Edap Tms employs 215 workers across the globe. What is Edap Tms' official website? The official website for Edap Tms is www.edap-tms.com. How can I contact Edap Tms? Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected] This page was last updated on 8/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
